Metabolomics and Network Pharmacology Analysis of Yiqi Huazhuo Decoction in Regulating EGFR Signaling and Metabolic Pathways in Type 2 Diabetes with Insulin Resistance: In Vivo Validation
YD ameliorates T2DM-IR and hepatic ELD by modulating EGFR signaling and metabolic pathways, providing multi-omics evidence for its clinical application.
Authors
- Siying Weng (ORCID: https://orcid.org/0000-0002-9110-1098)
- Sinan Li (ORCID: https://orcid.org/0000-0001-9519-2321)
- Jiaying Liu (ORCID: https://orcid.org/0000-0002-1274-3800)
Institutions
- Zhejiang Chinese Medical University (CN)
- Ningbo No. 2 Hospital (CN)
- Ningbo University Affiliated Hospital (CN)
Publication Details
- Journal
- Current Drug Metabolism
- Published
- 2025-09-26
- DOI
- https://doi.org/10.2174/0113892002424452250905064705
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00